Arrowhead Pharmaceuticals, Inc 10-K for FY2024
Arrowhead Pharmaceuticals, Inc. (ARWR)
10-K
2024-11-26
For: 2024-09-30
View Original
Added on
April 08, 2026
About this 10-K
Arrowhead Pharmaceuticals, Inc filed this 10-K on November 26, 2024, covering the fiscal year ended September 30, 2024 (FY2024).
Headline figures
Fiscal year ended September 30, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $3.55M
- down 98.5% from $240.74M a year earlier
- Net loss
- $599.49M
- compared with a net loss of $205.28M a year earlier
- Diluted EPS
- -$5.00
- compared with -$1.92 a year earlier